Erin Wright
Stock Analyst at Morgan Stanley
(4.50)
# 296
Out of 5,149 analysts
253
Total ratings
64.77%
Success rate
14.59%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Maintains: Underweight | $58 → $61 | $80.21 | -23.95% | 6 | Feb 25, 2026 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $22 → $24 | $24.88 | -3.54% | 13 | Feb 25, 2026 | |
| PSX Phillips 66 | Maintains: Equal-Weight | $140 → $147 | $159.78 | -8.00% | 3 | Feb 5, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $154 → $169 | $182.64 | -7.47% | 26 | Feb 5, 2026 | |
| HUM Humana | Downgrades: Underweight | $262 → $174 | $181.58 | -4.17% | 6 | Feb 2, 2026 | |
| COR Cencora | Upgrades: Overweight | $361 → $400 | $371.44 | +7.69% | 2 | Jan 29, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $224 → $245 | $226.35 | +8.24% | 13 | Jan 29, 2026 | |
| OPCH Option Care Health | Maintains: Overweight | $35 → $38 | $31.20 | +21.79% | 2 | Jan 13, 2026 | |
| ELV Elevance Health | Maintains: Equal-Weight | $359 → $352 | $284.03 | +23.93% | 5 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $89 → $93 | $80.49 | +15.54% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $211 → $175 | $125.93 | +38.97% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $995.69 | -8.00% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $635.54 | +26.66% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $204 | $144.81 | +40.87% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $32 | $40.65 | -21.28% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $28.67 | -40.70% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $52.27 | -50.26% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $283.93 | +37.36% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.73 | +17.22% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $13.30 | +72.93% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $208.36 | -17.45% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $289.21 | +102.97% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $282.99 | +6.01% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $8.78 | +378.36% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $204.01 | +41.17% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $175.69 | +100.35% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.69 | +1,092.41% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $465.38 | -61.11% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $78.84 | -78.44% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $26.84 | +350.82% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $508.10 | +14.15% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $7.24 | +383.43% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $108.70 | +88.59% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $13.79 | -20.23% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $173.96 | -9.75% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $667.82 | -53.88% | 1 | Oct 25, 2017 |
Henry Schein
Feb 25, 2026
Maintains: Underweight
Price Target: $58 → $61
Current: $80.21
Upside: -23.95%
Elanco Animal Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $24.88
Upside: -3.54%
Phillips 66
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $140 → $147
Current: $159.78
Upside: -8.00%
Align Technology
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $154 → $169
Current: $182.64
Upside: -7.47%
Humana
Feb 2, 2026
Downgrades: Underweight
Price Target: $262 → $174
Current: $181.58
Upside: -4.17%
Cencora
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $371.44
Upside: +7.69%
Cardinal Health
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $226.35
Upside: +8.24%
Option Care Health
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $31.20
Upside: +21.79%
Elevance Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $284.03
Upside: +23.93%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $80.49
Upside: +15.54%
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $125.93
Upside: +38.97%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $995.69
Upside: -8.00%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $635.54
Upside: +26.66%
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $144.81
Upside: +40.87%
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $40.65
Upside: -21.28%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $28.67
Upside: -40.70%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $52.27
Upside: -50.26%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $283.93
Upside: +37.36%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.73
Upside: +17.22%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $13.30
Upside: +72.93%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $208.36
Upside: -17.45%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $289.21
Upside: +102.97%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $282.99
Upside: +6.01%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $8.78
Upside: +378.36%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $204.01
Upside: +41.17%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $175.69
Upside: +100.35%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.69
Upside: +1,092.41%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $465.38
Upside: -61.11%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $78.84
Upside: -78.44%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $26.84
Upside: +350.82%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $508.10
Upside: +14.15%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $7.24
Upside: +383.43%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $108.70
Upside: +88.59%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $13.79
Upside: -20.23%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $173.96
Upside: -9.75%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $667.82
Upside: -53.88%